The authors of this book address all individuals approaching the study of nanomedicine for the first time ever, as well as those already profitably working in the field either as scientists, doctors, lawyers, or entrepreneurs. Teeming with accurate, up-to-date, and enjoyable content, the book describes some enlightening facts and figures pertaining
Commercializing Nanotechnology: A Roadmap to Taking Nanoproducts from Laboratory to Market provides a step-by-step roadmap for taking the results of laboratory research on nanotechnology and nanomaterials and developing them into successful and profitable commercial ventures. It details the methodology, techniques, and pathways for technology-readiness assessment, testing protocols, and commercialization, and it discusses manufacturing techniques, including their limitations and challenges. Provides methodology, techniques, and pathways for technology-readiness assessment, testing protocols, and commercialization Offers general direction and assistance to researchers Describes manufacturing techniques, including their limitations and challenges Discusses intellectual property protection Provides details on market opportunities This book is aimed at scientists and engineers, including chemists, physicists, economists, medical practitioners, managers, marketers, traders, investors, and entrepreneurs in the fields of nanoscience, nanomedicine, nanoengineering, and nanomanufacturing.
Nanotechnology is a multidisciplinary field that is revolutionizing the way we detect and treat damage to the human body. Nanomedicine applies nanotechnology to highly specific medical interventions for the prevention, diagnosis, and treatment of diseases. They are increasingly being used to overcome biological barriers in the body to improve the way we deliver compounds to specific tissues and organs. In particular, nanomedicines have been shown to be beneficial for stabilizing therapeutic compounds, overcoming obstacles to cellular and tissue uptake, and improving biodistribution of compounds to target sites in vivo. Nanomedicines have demonstrated significant therapeutic advantages for a multitude of biomedical applications, however the clinical translation of these nanotechnology platforms has not progressed as quickly as the plethora of positive results would have suggested. Understanding the advances in nanomedicine to date and the challenges that still need to be overcome, will allow future research to improve on existing platforms and to address the current translational and regulatory limitations. This eBook “Advances and Challenges in Nanomedicine” has brought together experts in the fields of nanomedicine, nanotechnology, nanotoxicology, pharmaceutics, manufacturing, and translation to discuss the application of nanotechnology to drug delivery. This information is presented as original research, opinion, perspective, and review articles. The goal of this eBook is to generate collaborative discussion on the current status, general trends, challenges, strategies, and future direction of pharmaceutical nanotechnology, as well as highlight current and emerging nanoparticulate platforms with potential medical applications.
Micro-nanotechnologies (MNT) are already making a profound impact on our daily lives. New applications are well underway in the US, Asia, and Europe. However, their potentially disruptive nature, along with the public's concerns, has produced a number of challenges. Commercializing Micro-Nanotechnology Products provides a snapshot of the cur
In terms of commercialization, nanomaterials occupy a unique place in nanotechnology. Engineered nanomaterials, especially nanoparticulate materials, are the leading sector in nanotechnology commercialization. In addition, the nanomaterial sector has attracted much more heated debate than any other nanotechnology sector with regard to safety, regul
This book provides a comprehensive overview of the recent trends in various Nanotechnology-based therapeutics and challenges associated with its development. Nanobiotechnology is an interdisciplinary research that has wide applications in the various fields of biomedical research. The book discusses the various facets of the application of Nanotechnology in drug delivery, clinical diagnostics, Nanomedicine and treatment of infectious and chronic diseases. The book also highlights the recent advancements on important devices and applications that are based on Nanotechnology in medicine and brief the regulatory and ethical issues related to nanomedical devices. It also reviews the toxicological profile of various nanomaterials and emphasizes the need for safe nanomaterials for clinical use. Finally, the book discusses the recent developments of potential commercial applications of Nanotechnology.
This book introduces readers from diverse backgrounds to the principles underlying nanotechnology, from devices to systems, while also describing in detail how businesses can use nanotechnology to redesign their products and processes, in order to have a clear edge over their competition. The authors include 75 case studies, describing in a highly-accessible manner, real nanotechnology innovations from 15 different industrial sectors. For each case study, the technology or business challenges faced by the company are highlighted, the type of nanotechnology adopted is defined, and the eventual economic and social impact is described. Introduces fundamentals of nanotechnology and its applications in a highly-accessible manner Includes 75 case studies of commercializing nanotechnology from 15 industrial sectors, including Automotive, Consumer Electronics, and Renewable Energy Enables nanotechnology experts to learn simple and important business concepts to facilitate the transfer of science to the market Introduces business owners to various means to resolve industrial challenges using nanotechnologies
This book is the third volume on this subject and focuses on the recent advances of nanopharmaceuticals in cancer, dental, dermal and drug delivery applications and presents their safety, toxicity and therapeutic efficacy. The book also includes the transport phenomenon of nanomaterials and important pathways for drug delivery applications. It goes on to explain the toxicity of nanoparticles to different physiological systems and methods used to assess this for different organ systems using examples of in vivo systems.
Nanomedicine is defined as the application of nanobiotechnology in clinical medicine, which is currently being used to research the pathomechanism of disease, refine molecular diagnostics, and aid in the discovery, development, and delivery of drugs. In The Handbook of Nanomedicine, Third Edition, Prof. Kewal K. Jain updates, reorganizes, and replaces information in the comprehensive second edition in order to capture the most recent advances in this dynamic field. Important components of nanomedicine such as drug delivery via nanobiotechnology and nanopharmaceuticals as well as nanooncology, where the greatest number of advances are occurring, are covered extensively. As this text is aimed at nonmedical scientists, pharmaceutical personnel, as well as physicians, descriptions of the technology involved and other medical terminology are kept as clear and simple as possible. In depth and cutting-edge, The Handbook of Nanomedicine, Third Edition informs its readers of the ever-growing field of nanomedicine, destined to play a significant role in the future of healthcare.